Blonde L, Brunton SA, Chava P, Zhou R, Meyers J, Davis KL, Dalal MR, Digenio A. Achievement of target A1C <7.0% (<53 mmol/mol) by U.S. type 2 diabetes patients treated with basal insulin in both randomized controlled trials and clinical practice. Diabetes Spectr. 2018 Nov;31(4). doi: 10.2337/ds17-0082
Loughlin AM, Qiao Q, Nunes AP, Ezzy SM, Yochum L, Clifford CR, Gately RV, Dore DD, Seeger JD. Effectiveness and tolerability of therapy with once-weekly exenatide versus basal insulin among injectable-naive patients with type 2 diabetes in a real-world setting in the United States. Diabetes Spectr. 2018 May;31(2):129-37. doi: 10.2337/ds16-0081
Setji T, Hopkins TJ, Jimenez M, Manning E, Shaughnessy M, Schroeder R, Mendoza-Lattes S, Spratt S, Westover J, Aronson S. Rationalization, development, and implementation of a preoperative diabetes optimization program designed to improve perioperative outcomes and reduce cost. Diabetes Spectr. 2017 Aug;30(3):217-23.
Donnelly DW, Hegarty A, Sharp L, Carsin AE, Deady S, McCluskey N, Comber H, Gavin A. The impact of adjustment for socioeconomic status on comparisons of cancer incidence between two European countries. J Cancer Epidemiol. 2013 Jan 1;2013:612514. doi: 10.1155/2013/612514
Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.